Article Text

Download PDFPDF
Clinical science
Outcomes of staged conjunctival flap and corneal transplantation for infectious keratitis resistant to medical treatment
  1. Raphael Kilian1,2,
  2. Marco Pellegrini1,2,
  3. Angeli Christy Yu1,2,
  4. Valentino de Ruvo1,2,
  5. Niccolò Salgari1,2,
  6. Massimo Busin1,2
  1. 1 Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
  2. 2 Istituto Internazionale per la Ricerca e Formazione in Oftalmologia (IRFO), Forlì, Italy
  1. Correspondence to Dr Valentino de Ruvo; drvvnt{at}unife.it

Abstract

Background/Aims To explore the outcomes of conjunctival flap (CF) followed by keratoplasty in patients with severe infectious keratitis (IK) unresponsive to medical treatment.

Methods This is a retrospective monocentric study including 29 eyes of 29 patients with IK resistant to antibiotic treatment associated with stromal ulcer deepening to ≥50% of corneal thickness. All eyes underwent Gundersen’s CF procedure and penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK) or mushroom keratoplasty (MK), at least 4 months thereafter. Outcome measures included corrected distance visual acuity (CDVA), endothelial cell count (ECC), graft survival and complications.

Results IK healed in all eyes following CF. The mean time interval between CF and keratoplasty was 16.3±16.1 months. 55% of patients underwent PK, 35% MK and 10% DALK. Mean follow-up duration was 39.6±34.3 months. At the last available follow-up, a CDVA≥20/200 was obtained in 50%, 33.3% and 70% of cases, respectively after PK, DALK and MK. Mean annual endothelial cell loss was 24.5% following PK and 10.7% following MK. Overall, graft failure occurred in 75% of cases after PK, 100% after DALK and 20% after MK. The most frequent complications were endothelial decompensation without immunological rejection (34.5%, after 31.1±25.1 months) and graft rejection (17.2%, after 10.2±7.9 months, all in the PK group).

Conclusion CF surgery followed by staged keratoplasty represents an alternative therapeutic approach to avoid high-risk keratoplasty ‘a chaud’ in cases of severe IK.

  • Cornea
  • Infection
  • Treatment Surgery

Data availability statement

Data are available upon reasonable request. Data are available on reasonable request.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Data are available on reasonable request.

View Full Text

Footnotes

  • Contributors Supervision: MB; conceptualisation: RK, MB; writing – original draft: RK; writing – review and editing: MP, ACY, VdR, NS, MB; data curation: MP, ACY, VdR, NS, MB; visualisation: VdR, NS; guarantor: RK.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.